Randomized, double-blinded, multicenter, phase II study of pemetrexed, carboplatin, and Bevacizumab with enzastaurin or placebo in chemonaïve patients with stage IIIB/IV non-small cell lung cancer: Hoosier oncology group LUN06-116

Erin M. Casey, Wael Harb, Daniel Bradford, Jose Bufill, Sreenivasa Nattam, Jyoti Patel, William Fisher, Jane E. Latz, Xiaochun Li, Jingwei Wu, Nasser Hanna*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

23 Scopus citations

Fingerprint Dive into the research topics of 'Randomized, double-blinded, multicenter, phase II study of pemetrexed, carboplatin, and Bevacizumab with enzastaurin or placebo in chemonaïve patients with stage IIIB/IV non-small cell lung cancer: Hoosier oncology group LUN06-116'. Together they form a unique fingerprint.

Medicine & Life Sciences